Year: 2020

VANCOUVER, British Columbia, Dec. 23, 2020 (GLOBE NEWSWIRE) — Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, announced today a message from the CEO and Chairman of Aequus, Doug Janzen.Dear Friends,Merry Christmas, Happy Hanukkah, and Seasons Greetings to all our shareholders, clinician partners, patients, and customers.As we approach the final days of 2020, we would like to recognize the dedication and resilience of our team, who have worked diligently to achieve major milestones and continued growth for Aequus, while overcoming unprecedented challenges. Together we have added additional products to our commercial pipeline and became exceptionally agile in reaching our customers and creating growth, despite the...

New York, NY, Dec. 23, 2020 (GLOBE NEWSWIRE) — Better World Acquisition Corp. (NASDAQ: BWACU) (the “Company”) announced that, commencing December 28, 2020, holders of the units sold in the Company’s initial public offering may elect to separately trade shares of the Company’s common stock and warrants included in the units. Common stock and warrants that are separated will trade on the Nasdaq Capital Market under the symbols “BWAC” and “BWACW,” respectively. Those units not separated will continue to trade on the Nasdaq Capital Market under the symbol “BWACU.”This press release shall not constitute an offer to sell or the solicitation of an offer to buy the securities of the Company, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration...

NEW YORK, Dec. 23, 2020 (GLOBE NEWSWIRE) — Fortress Transportation and Infrastructure Investors LLC (NYSE:FTAI) (the “Company” or “FTAI”) announced today the early settlement of its previously announced cash tender offer to purchase up to $300 million aggregate principal amount (the “Maximum Tender Amount”) of its 6.75% senior notes due 2022 (the “Notes”), upon the terms and conditions included in the Offer to Purchase, dated December 9, 2020 (the “Offer to Purchase”).The table below identifies, among other things, the aggregate principal amount of Notes validly tendered and not validly withdrawn as of 5:00 p.m., New York City time, on December 22, 2020 (the “Early Tender Deadline”), the aggregate principal amount of Notes that the Company has accepted for purchase and the approximate proration factor.The Early Tender Deadline has...

BATON ROUGE, La., Dec. 23, 2020 (GLOBE NEWSWIRE) — Amedisys, Inc. (NASDAQ: AMED), America’s leading independent home health, hospice and personal care company, today announced that its Board of Directors has authorized a stock repurchase program, under which the Company may repurchase up to $100 million of its outstanding common stock through December 31, 2021.Scott Ginn, Chief Financial Officer, stated, “Given our strong cashflow and low leverage, we feel it is prudent to have authorization to buy-back shares throughout the course of the year, including shares granted under the Company’s Omnibus Incentive Plan as they vest in 2021. This will become a recurring part of our capital deployment strategy; however, our first priority is and will continue to be accretive acquisitions in both Home Health and Hospice.”Under the stock repurchase...

BRENTWOOD, Tenn., Dec. 23, 2020 (GLOBE NEWSWIRE) — CoreCivic, Inc. (NYSE: CXW) (the “Company”) announced today that following an extensive and ongoing marketing process for the proposed sale of certain non-core real estate assets in its CoreCivic Properties segment, it closed on the sale of 42 of its non-core government leased properties to a third party for an aggregate purchase price of $106.5 million. The assets sold represented approximately 573,000 gross rentable square feet and are expected to generate approximate net proceeds of $27.0 million, following repayment of non-recourse mortgage notes associated with some of the properties and other transaction-related costs. Net cash proceeds will be utilized to repay borrowings under the Company’s revolving credit facility.“We are pleased with the positive market...

NEW YORK, Dec. 23, 2020 (GLOBE NEWSWIRE) — PropTech Acquisition Corporation (NASDAQ: PTAC) (“PropTech” or “PTAC”) and Porch.com, Inc. (“Porch” or “the Company”) jointly announced today that they have closed their previously announced business combination (the “Business Combination”).With the closing, the combined company has been renamed “Porch Group, Inc.” and its common stock and warrants will begin trading on The Nasdaq Stock Market (“Nasdaq”) under the ticker symbols “PRCH” and “PRCHW” on Thursday, December 24, 2020. To celebrate the closing, Porch Founder and CEO Matt Ehrlichman will ring the opening bell virtually on the Nasdaq Stock Exchange at 9:30 a.m. Eastern time on December 24th.“Today is a momentous day for our company, our employees and our shareholders,” said Porch Founder and CEO Matt Ehrlichman....

MONROE TOWNSHIP, N.J., Dec. 23, 2020 (GLOBE NEWSWIRE) — Ocean Power Technologies, Inc. (“OPT” or “the Company”) (NASDAQ: OPTT), a leader in innovative and cost-effective ocean energy solutions, today announced that Clyde W. Hewlett, Diana G. Purcel, and Peter E. Slaiby were elected to its Board of Directors by the Company stockholders at the 2020 Annual General Meeting effective December 23, 2020.“We are excited to welcome Clyde, Diana, and Pete as new independent directors to the OPT board. These new directors bring valuable expertise in offshore energy, safety, and finance and governance, and join OPT at an exciting time. We have proven products and solutions ready for commercialization, a receptive marketplace, access to capital, and a dedicated and experienced team to continue innovations towards...

ROSEMONT, Ill., Dec. 23, 2020 (GLOBE NEWSWIRE) — Wintrust Financial Corporation (“Wintrust”) (Nasdaq: WTFC) today announced it will release its fourth quarter and year-to-date 2020 earnings results after the market closes on Wednesday, January 20, 2021 and host a conference call on Thursday, January 21, 2021 at 10:00 a.m. (CDT). Individuals interested in participating in the call should dial 877-363-5049 and enter Conference ID #9780585 or a simultaneous audio-only web cast may be accessed via the Company’s web site at http://www.wintrust.com, Investor Relations link.   An accompanying slide presentation for those participating in the call or listening via web cast will be available on the Company’s web site at http://www.wintrust.com, Investor Relations link.A replay of the audio-only webcast and an accompanying slide...

ATHENS, Greece, Dec. 23, 2020 (GLOBE NEWSWIRE) — TEN, Ltd (“TEN” or the “Company”) (NYSE: TNP) today announced 24-month charters extensions with profit sharing provisions for two product tankers to a major oil concern. Excluding options for an additional 12-month period at expiration of this fixture, the combined minimum revenues from these contracts are expected at around $20.0 million. Should the additional options get exercised, the total minimum revenues could surpass $32 million.“Following our stated policy, these charters to first-class counterparties provide earnings visibility and upside potential. This flexibility has become the cornerstone of our strategy over the years and has served the Company well in navigating smoothly the market cyclicality,” Mr. George Saroglou, Chief Operating Officer of TEN stated. “As we leave...

Data presented throughout 2020 have validated the potential of the PATrOL™ platform to develop highly targeted therapies that increase, decrease or change causal protein functionPlan to provide updates on development pipeline, including the myotonic dystrophy type 1 (DM1) and Huntington’s disease (HD) programs, at an R&D day in the first half of CY2021PITTSBURGH, Pa., Dec. 23, 2020 (GLOBE NEWSWIRE) — NeuBase Therapeutics, Inc. (Nasdaq: NBSE) (“NeuBase” or the “Company”), a biotechnology company accelerating the genetic revolution using a new class of synthetic medicines, today reported its financial results for the fiscal year ended September 30, 2020.“Throughout 2020, we successfully executed against our development strategy, most notably with the generation of two very exciting datasets supporting our initial therapeutic...